COVID-19 Pandemic at a Tipping Point: WHO
Organization’s International Health Regulations Emergency Committee met last week to discuss COVID-19
Organization’s International Health Regulations Emergency Committee met last week to discuss COVID-19
How to regulate CBD supplements has become a pressing public health concern as the popularity of CBD supplements has exploded in the United States
Draft recommendations around the new policy center on ‘individual risk-based questions to reduce the risk of transfusion-transmitted HIV’
Increases seen compared with states where neither recreational nor medical legalization has occurred
New revised leaflets now clearly state that Plan B and its kin work ‘before release of an egg from the ovary’
Decision comes as the nation suffers from an unusually early and hard flu season, with about 9,300 deaths so far
Based on the information presented at the meeting, the FDA will make a decision on the best course of action regarding adjustments to current authorizations and approvals.
Red flags include pharmacies that do not require a doctor’s prescription or have a licensed pharmacist to answer questions
Findings include exclusion of people with cognitive, visual, hearing, mobility, and other disabilities, without documented justification
Move is in line with efforts to wind down other COVID-19-related tools on the CDC website